Related references
Note: Only part of the references are listed.Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme
Yara El-Dash et al.
BIOORGANIC CHEMISTRY (2021)
Synthesis and Biological Evaluation of 5-benzyl-3-pyridyl-1H-1,2,4-triazole Derivatives as Xanthine Oxidase Inhibitors
Song-Ye Li et al.
MEDICINAL CHEMISTRY (2020)
Synthesis and bioevaluation of 1-phenylimidazole-4-carboxylic acid derivatives as novel xanthine oxidoreductase inhibitors
Haiyan Zhou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Synthesis, Molecular Docking, DFT Study of Novel N-Benzyl-2-(3-cyano-4-isobutoxyphenyl)- 4-methylthiazole-5-carboxamide Derivatives and their Antibacterial Activity
D. Sam Daniel Prabu et al.
ASIAN JOURNAL OF CHEMISTRY (2020)
Development of novel NLRP3-XOD dual inhibitors for the treatment of gout
Weiwei Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
New pyrazole derivatives possessing amino/methanesulphonyl pharmacophore with good gastric safety profile: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory activity and histopathological studies
Khaled R. A. Abdellatif et al.
BIOORGANIC CHEMISTRY (2020)
Novel pyrazine based anti-tubercular agents: Design, synthesis, biological evaluation and in silico studies
Nayera W. Hassan et al.
BIOORGANIC CHEMISTRY (2020)
Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors
Ehab M. Gedawy et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Design, synthesis and biological evaluation of 1-alkyl-5/6-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-y1)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors
Jun Gao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases
Perihan A. Elzahhar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE2, TNF-α, IL-6 and histopathological study
Madlen B. Labib et al.
BIOORGANIC CHEMISTRY (2020)
Cardiovascular disease and uric acid: is the not-so-innocent bystander becoming a true culprit and does the US black box warning for febuxostat indicate that not all uric acid lowering is beneficial?
Franz H. Messerli et al.
EUROPEAN HEART JOURNAL (2019)
A review on: Analysis of certain drugs used in gout treatment
Noha M. Hosny et al.
MICROCHEMICAL JOURNAL (2019)
Studies of febuxostat analogues as xanthine oxidase inhibitors through 3D-QSAR, Topomer CoMFA and molecular modeling
Hongjin Tang et al.
JOURNAL OF THE IRANIAN CHEMICAL SOCIETY (2019)
Febuxostat attenuates ulcerative colitis by the inhibition of NF-κB, proinflammatory cytokines, and oxidative stress in mice
Keyvan Amirshahrokhi
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Anti-Inflammatory and Anti-Hyperuricemic Functions of Two Synthetic Hybrid Drugs with Dual Biological Active Sites
Rafa S. Almeer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
COX-1/COX-2 inhibition assays and histopathological study of the new designed anti-inflammatory agent with a pyrazolopyrimidine core
Eman K. A. Abdelall et al.
BIOORGANIC CHEMISTRY (2019)
Gout and cardiovascular disease: crystallized confusion
Aryeh M. Abeles et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies
Nehad A. El-Sayed et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Toward an Understanding of Structural Insights of Xanthine and Aldehyde Oxidases: An Overview of their Inhibitors and Role in Various Diseases
Raj Kumar et al.
MEDICINAL RESEARCH REVIEWS (2018)
Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles
Itrat Fatima et al.
BIOORGANIC CHEMISTRY (2018)
Design, synthesis and biological evaluation of novel xanthine oxidase inhibitors bearing a 2-arylbenzo[b]furan scaffold
Hong-Jin Tang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design, synthesis and bioevaluation of 2-mercapto-6-phenylpyrimidine-4-carboxylic acid derivatives as potent xanthine oxidase inhibitors
Ailong Shi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
William B. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Design, synthesis and biological evaluation of lazabemide derivatives as inhibitors of monoamine oxidase
Shiyang Zhou et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Design, synthesis, and biological evaluation of 5-(4-(pyridin-4-yl)-1H-1,2,3-triazol-1-yl)benzonitrile derivatives as xanthine oxidase inhibitors
Ting-jian Zhang et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2018)
Synthesis and bioevaluation of 1-phenyl-pyrazole-4-carboxylic acid derivatives as potent xanthine oxidoreductase inhibitors
Jing Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis, screening and docking of fused pyrano[3,2-d]pyrimidine derivatives as xanthine oxidase inhibitor
Manroopraj Kaur et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Structure-activity relationships for the synthesis of selective cyclooxygenase 2 inhibitors: an overview (2009-2016)
G. Carullo et al.
MEDCHEMCOMM (2017)
Discovery and biological evaluation of some (1H-1,2,3-triazol-4-yl) methoxybenzaldehyde derivatives containing an anthraquinone moiety as potent xanthine oxidase inhibitors
Ting-jian Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Development of 2-(Substituted Benzylamino)-4-Methyl-1, 3-Thiazole-5-Carboxylic Acid Derivatives as Xanthine Oxidase Inhibitors and Free Radical Scavengers
Md Rahmat Ali et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2016)
Synthesis, anti-inflammatory, analgesic and COX-1/2 inhibition activities of anilides based on 5,5-diphenylimidazolidine-2,4-dione scaffold: Molecular docking studies
Alaa A. -M. Abdel-Aziz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives
Khaled R. A. Abdellatif et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Febuxostat in the management of hyperuricemia and chronic gout: a review
Brian Tomlinson
Therapeutics and Clinical Risk Management (2016)
Synthesis and bioevaluation of 2-phenyl-5-methyl-2H-1,2,3-triazole-4-carboxylic acid/carbohydrazide derivatives as potent xanthine oxidase inhibitors
Ailong Shi et al.
RSC ADVANCES (2016)
Xanthine Oxidase: Isolation, Assays of Activity, and Inhibition
Danijela A. Kostic et al.
JOURNAL OF CHEMISTRY (2015)
Design, synthesis, in silico and in vitro studies of novel 4-methylthiazole-5-carboxylic acid derivatives as potent anti-cancer agents
Ravendra Babu Kilaru et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Synthesis and xanthine oxidase inhibitory activity of 5,6-dihydropyrazolo/pyrazolo[1,5-c]quinazoline derivatives
Deependra Kumar et al.
BIOORGANIC CHEMISTRY (2014)
Ligand efficiency metrics considered harmful
Peter W. Kenny et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2014)
Augmenting the Xanthine Oxidase Inhibitory Activity of Febuxostat by its Structural Modification
Kuruva Chandra Sekhar et al.
Letters in Drug Design & Discovery (2014)
The role of ligand efficiency metrics in drug discovery
Andrew L. Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
The Crystallization of Monosodium Urate
Miguel A. Martillo et al.
CURRENT RHEUMATOLOGY REPORTS (2014)
3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: A potential therapeutic agent for treatment of hyperuricemia and gout
Jian-Ming Lue et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Identification of novel isocytosine derivatives as xanthine oxidase inhibitors from a set of virtual screening hits
Chandrika B-Rao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
POMA analyses as new efficient bioinformatics' platform to predict and optimise bioactivity of synthesized 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues
Mohamed Jawed Ahsan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Latest evidence on gout management: what the clinician needs to know
Christopher M. Burns et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2012)
Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout
Robert T. Keenan et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Synthesis of some 5-phenylisoxazole-3-carboxylic acid derivatives as potent xanthine oxidase inhibitors
Shaojie Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Management of hyperuricemia in gout: focus on febuxostat
Mark Reinders et al.
Clinical Interventions in Aging (2010)
Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents
Sherif A. F. Rostom et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Design, synthesis, and pharmacological and pharmacokinetic evaluation of 3-phenyl-5-pyridyl-1,2,4-triazole derivatives as xanthine oxidoreductase inhibitors
Takahiro Sato et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Synthesis and in vitro anticancer activity of 2,4-azolidinedione-acetic acids derivatives
Danylo Kaminskyy et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
An extremely potent inhibitor of xanthine oxidoreductase - Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition
K Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Rate-limited steps of human oral absorption and QSAR studies
YH Zhao et al.
PHARMACEUTICAL RESEARCH (2002)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Progress towards the discovery of xanthine oxidase inhibitors
F Borges et al.
CURRENT MEDICINAL CHEMISTRY (2002)
Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: Structure-based mechanism of conversion
C Enroth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
